
NYSEHealthcareMedical - Distribution
最新資料
US$0.3905
−US$0.0375 · -8.76%
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
前收盤價
US$0.3905
−US$0.0375 · -8.76%
盤前
US$0.3947
+US$0.0042 · +1.08%
10月13日 上午7:59 ET
盤中時間採用ET。市場資料可能有所延遲。
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
日內區間
目前US$0.3905
52週區間
目前US$0.3905
盤中時間採用ET。市場資料可能有所延遲。
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
日內區間
目前US$0.3905
52週區間
目前US$0.3905
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 27.62億 USD | 107.01億 USD | 103.34億 USD | 99.55億 USD | 97.85億 USD |
| 銷貨成本 | 14.73億 USD | 84.82億 USD | 82.09億 USD | 81.29億 USD | 82.72億 USD |
| 毛利 | 12.89億 USD | 22.19億 USD | 21.25億 USD | 18.26億 USD | 15.13億 USD |
| 研究與開發 | — | — | — | — | 1210萬 USD |
| 銷售、一般及管理費用 | 10.68億 USD | 19.1億 USD | 18.14億 USD | 15.55億 USD | 10.77億 USD |
| 營業費用 | 10.68億 USD | 24.27億 USD | 20.21億 USD | 16.83億 USD | 11.45億 USD |
| 利息支出 | 1.07億 USD | 1.44億 USD | 1.58億 USD | 1.29億 USD | 4809萬 USD |
| 折舊和攤銷 | 2.15億 USD | 2.65億 USD | 2.87億 USD | 2.29億 USD | 9062.1萬 USD |
| 營業利益 | 2.22億 USD | −2.08億 USD | 1.05億 USD | 1.43億 USD | 3.68億 USD |
| 淨利 | −11.01億 USD | −3.63億 USD | −4130.1萬 USD | 2238.9萬 USD | 2.22億 USD |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$1.50
上漲空間 284.12%年度分割調整後的每股現金分配。
US$0.009
2021年(完整年度)-99.1% 自從 2017
US$1.03
2,017
US$0.855
2,018
US$0.01
2,019
US$0.0095
2,020
US$0.009
2,021
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2021年12月14日 | US$0.002Quarterly | 2021年12月15日 | 2021年12月31日 |
股息 | 2021年9月14日 | US$0.002Quarterly | 2021年9月15日 | 2021年9月30日 |
股息 | 2021年6月14日 | US$0.0025Quarterly | 2021年6月15日 | 2021年6月30日 |
股息 | 2021年3月12日 | US$0.0025Quarterly | 2021年3月15日 | 2021年3月31日 |
股息 | 2020年12月14日 | US$0.0025Quarterly | 2020年12月15日 | 2020年12月31日 |
股息 | 2020年9月14日 | US$0.002Quarterly | 2020年9月15日 | 2020年9月30日 |
除息 2021年12月14日
US$0.002
Quarterly
2021年12月15日登記 · 支付日 2021年12月31日
除息 2021年9月14日
US$0.002
Quarterly
2021年9月15日登記 · 支付日 2021年9月30日
除息 2021年6月14日
US$0.0025
Quarterly
2021年6月15日登記 · 支付日 2021年6月30日
除息 2021年3月12日
US$0.0025
Quarterly
2021年3月15日登記 · 支付日 2021年3月31日
除息 2020年12月14日
US$0.0025
Quarterly
2020年12月15日登記 · 支付日 2020年12月31日
除息 2020年9月14日
US$0.002
Quarterly
2020年9月15日登記 · 支付日 2020年9月30日
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI264.5萬0.00%2.3兆 USD0.03%US$381.57—
Vanguard U.S. Value Factor ETFVFVA145.96萬0.17%——US$154.42—
Vanguard Extended Market ETFVXF100.83萬0.00%954億 USD0.05%US$233.52—
iShares Russell 2000 ETFIWM85.77萬0.00%787.4億 USD0.19%US$277.9—
Vanguard Russell 2000 ETFVTWO49.98萬0.00%180億 USD0.06%US$112.27—
Schwab Fundamental U.S. Small Company Index ETFFNDA49.15萬0.01%87.72億 USD0.25%US$35.60—
U.S. Small Cap Value Portfolio ETF Class SharesDFSV22.65萬0.00%268.33億 USD0.33%US$37.98—
Vanguard Health Care ETFVHT22.64萬0.00%220億 USD0.09%US$320.67—
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard U.S. Value Factor ETFVFVA
Vanguard Extended Market ETFVXF
iShares Russell 2000 ETFIWM
Vanguard Russell 2000 ETFVTWO
Schwab Fundamental U.S. Small Company Index ETFFNDA
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Health Care ETFVHTAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。